Skip to the page

Data / Drug companies / Antidote

Antidote drugs: 3 drugs from 24 companies in the FDA NDC directory

Antidote is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 46 products in this class from 24 companies, covering 3 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on June 1, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 24Companies
  • 46Products
  • 3Drugs by generic name

Drugs in the Antidote class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Acetylcysteine3415
Fomepizole76
Hydroxocobalamin33

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Fresenius Kabi USA, LLC10solution; injection, solutionGeneric drugs (ANDA)March 31, 2014
American Regent, Inc.6inhalant; injection, solutionGeneric drugs (ANDA)July 31, 2020
Somerset Therapeutics, LLC4solution; injection, solutionGeneric drugs (ANDA)March 4, 2025
Sagent Pharmaceuticals3injection, solution; injectionGeneric drugs (ANDA)November 15, 2023
Cameron Pharmaceuticals2solutionGeneric drugs (ANDA)August 21, 2025
Cardinal Health 107, LLC2inhalantGeneric drugs (ANDA)May 6, 2011
Hospira, Inc.2solutionGeneric drugs (ANDA)June 1, 2005
Actavis Pharma, Inc.1injection, solutionGeneric drugs (ANDA)November 12, 2010
BTG International Inc.1injection, powder, lyophilized, for solutionNew drug applications (NDA)December 15, 2021
Cumberland Pharmaceuticals Inc.1injection, solutionNew drug applications (NDA)January 23, 2004
Eugia US LLC1injection, solutionGeneric drugs (ANDA)February 29, 2016
Gland Pharma Limited1injectionGeneric drugs (ANDA)July 6, 2023
Glenmark Pharmaceuticals Inc., USA1injection, solutionGeneric drugs (ANDA)September 25, 2024
Guna Spa1pelletUnapproved homeopathic productsMay 23, 2006
Hikma Pharmaceuticals USA Inc.1injection, solutionGeneric drugs (ANDA)March 31, 2026
Indoco Remedies Limited1injectionGeneric drugs (ANDA)March 1, 2022
Mylan Institutional LLC1injection, solutionGeneric drugs (ANDA)October 9, 2012
Navinta LLC1injection, solutionGeneric drugs (ANDA)April 2, 2021
Onesource Specialty Pharma Limited1injection, solutionGeneric drugs (ANDA)April 26, 2023
Padagis US LLC1injectionAuthorized generics (NDA)December 20, 2012
PureTek Corporation1tabletOther unapproved drugsSeptember 14, 2023
Xellia Pharmaceuticals USA LLC1injection, solutionGeneric drugs (ANDA)June 10, 2023
Xseer Pharmaceuticals1injectionOther unapproved drugsJune 1, 2026
Zydus Pharmaceuticals USA Inc.1injection, solutionGeneric drugs (ANDA)March 18, 2021

Dosage forms

Dosage formProductsShare
Injection, solution1737%
Solution1532.6%
Inhalant613%
Injection510.9%
Injection, powder, lyophilized, for solution12.2%
Tablet12.2%
Pellet12.2%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.